Taurine

Taurine has been studied in 515 papers since 1975: 144 trials and 35 observational studies in people, 129 in animals, 42 in cells, 159 reviews; 81 in the past year. The newest story, Oct 24, 2026: “Raising taurine improves health during aging in mice”.

Intervention

515 papers study it122 more mention it820 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 23% faster than aging research as a whole: 27 papers in the latest year counted

More supplements

12 new papers in 30 daysSee all 559 papers on taurine

At a glance

Independent labs report that taurine extends worm lifespan; mouse studies and a monkey study report improved healthspan, while fly studies report shorter lifespan or no clear lifespan effect. Human trials report reduced oxidative stress, but a trial in men shows no clear physical-function effect. Some authors have company affiliations, and some papers declare company ties.

820 findings in 326 papers from 1975 to 2026, 16 of them since April 2026

Independent labs found the same change in cells, worms or flies, mice and people. 175 independent labs in 39 countries; 21 trials, 3 about aging, 6 with no results posted.

“taurine supplementation significantly improved markers of metabolic dysfunction (including hemoglobin A1c, fasting blood glucose, fasting insulin, HOMA-IR, total cholesterol, triglycerides, and low-density lipoprotein)”
Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysisBMC infectious diseases2026doi:10.1186/s12879-026-13009-y

36 of its findings point the other way.

Cells, worms or flies, mice and humans: replicated by independent labs.
  • 175 independent labs in 39 countries
  • 36 findings against
  • 21 trials, 3 about aging, 6 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 15 of 668 findings with company ties
  • Human trial116
  • Humans23
  • Animals108
  • Model organisms13
  • Cells35
  • In silico1

86 studies gave taurine to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on fatigue severitymean difference -1.25 (95% CI -3.55 to 1.05); p=0.288

down: Decreases fatigue severity-11.90±4.04 vs -4.57±9.23; Cohen's d -1.02

Randomized trial12 weeks220 peopleUnselected patients with decompensated cirrhosisHepatology communications, Apr 24, 2026

down: Decreases aspartate aminotransferase

down: Lowers the risk of mortalityp < 0.05

down: Decreases hospital staymean difference -3.49 days

Randomized trial30 days169 peopleadultsClinical nutrition ESPEN, Jan 26, 2026

up: Increases blood lactateT group peak values higher than P group (P = 0.04)

up: Increases tympanic temperatureT group peak values higher than P group (P < 0.01)

Randomized trial12 peopleDuring exhaustive exercise under hot and humid conditionsSports health, Feb 19, 2025

up: Improves countermovement jump height43.42 ± 3.46 vs 38.58 ± 3.86

Randomized trial16 people16 male university football players23.69 ± 2.15 yearsMale university football playersScientific reports, Feb 13, 2025

down: Decreases triglycerideWMD -0.56 mg/dL, 95% CI -0.92 to -0.2

down: Decreases fasting insulinWMD -2.15 μU/mL, 95% CI -3.24 to -1.06

down: Decreases HOMA-IRWMD -0.91, 95% CI -1.74 to -0.08

Review of trialslong-termadultsIn obese participants (subgroup analysis)Nutrients, Dec 27, 2024

What did lifespan studies of taurine find?

DrugAge

DrugAge records 9 results from 4 papers: 4 in D. melanogaster, 3 in C. elegans and 2 in mice. Average lifespan is the mean or the median, as each paper reports it.

What did studies of taurine find?

539

Studies of taurine measured 539 outcomes; the most studied are oxidative stress and ROS signaling (24 studies), inflammation (19) and apoptosis (10).

Oxidative stress and ROS signaling

downin reviews12downin mice4downin rats4downin humans3+1

24 studies
  1. Taurine decreases oxidative stress and ROS signaling in humans.

    Human trialn = 1,030

  2. Taurine decreases oxidative stress and ROS signaling in humans.

    Human trial3 g per day2 weeks

  3. Taurine decreases oxidative stress and ROS signaling in humans (measured by urinary 8-hydroxy-2-deoxyguanosine, GEE analysis over time) (Beta -0.54; 95% CI -1.08 to -0.01; p = 0.04).

    Human trialmeasured by urinary 8-hydroxy-2-deoxyguanosine, GEE analysis over time

  4. Taurine decreases oxidative stress and ROS signaling in humans (Beta -0.54, 95% CI -1.08 to -0.01, p = 0.04).

    Human trialup to six days after surgeryn = 60

  5. Taurine decreases oxidative stress and ROS signaling in rats (co-administered with paclitaxel) (MDA 0.81 nmol/mg protein).

    Animalsco-administered with paclitaxeltestis150 mg/kg/daymales

  6. Taurine decreases oxidative stress and ROS signaling.

    Review

  7. Taurine decreases oxidative stress and ROS signaling.

    Review

  8. Taurine decreases oxidative stress and ROS signaling in TCDD-exposed rats.

    Animalsin TCDD-exposed ratsheart200 mg/kg/day30 daysmales

  9. Taurine decreases oxidative stress and ROS signaling.

    Review

  10. Taurine decreases oxidative stress and ROS signaling in SICM mice.

    Animalsin SICM miceheart

All 25

More on Oxidative stress and ROS signaling

Inflammation

downin reviews9downin mice6downin cells1upin mice1+2

19 studies
  1. Taurine decreases inflammation (preclinical studies).

    Reviewpreclinical studies

  2. Taurine inhibits inflammation in mice (streptozotocin-induced diabetes).

    Animalsstreptozotocin-induced diabeteskidney

  3. Taurine increases inflammation in mice (ethanol exposure, paralleling bacterial translocation).

    Animalsethanol exposure, paralleling bacterial translocationliver3 g/kg body weight/daymales

  4. Taurine decreases inflammation in O. aries.

    Animalsintestine

  5. Taurine decreases inflammation.

    Review

  6. Taurine decreases inflammation in rats (gentamicin co-treatment).

    Animalsgentamicin co-treatmenthippocampus100 mg/kg/day15 daysmalesn = 32

  7. Taurine decreases inflammation in SICM mice.

    Animalsin SICM miceheart

  8. Taurine decreases inflammation in rotenone-induced PD model mice.

    Animalsin rotenone-induced PD model mice

  9. Taurine decreases inflammation in mice (Listeria monocytogenes infection).

    AnimalsListeria monocytogenes infection

  10. Taurine inhibits inflammation in bone metabolic diseases.

    Reviewin bone metabolic diseases

All 19

More on Inflammation

Apoptosis

downin reviews4downin rats3downin mice2downin Mus musculus; Sus scrofa cells1

10 studies
  1. Taurine decreases apoptosis in TCDD-exposed rats.

    Animalsin TCDD-exposed ratsheart200 mg/kg/day30 daysmales

  2. Taurine decreases apoptosis in SICM mice and LPS-stimulated AC16 cardiomyocytes.

    Animalsin SICM mice and LPS-stimulated AC16 cardiomyocytes

  3. Taurine decreases apoptosis in DBP-exposed mice.

    Animalsin DBP-exposed micefemales

  4. Taurine decreases apoptosis in Mus musculus; Sus scrofa cells (postovulatory oocyte aging).

    Cellspostovulatory oocyte agingoocytefemales

  5. Taurine prevents apoptosis.

    Review

  6. Taurine decreases apoptosis.

    Review

  7. Taurine prevents apoptosis (together with other osmolytes).

    Reviewtogether with other osmolytesbrain

  8. Taurine inhibits apoptosis in rats (isoflurane exposure).

    Animalsisoflurane exposurehippocampus

  9. Taurine prevents apoptosis following ER stress.

    Reviewfollowing ER stress

  10. Taurine decreases apoptosis in rats (alloxan-induced diabetes).

    Animalsalloxan-induced diabeteskidney

More on Apoptosis

Plasma taurine concentration

upin humans9

9 studies
  1. Taurine increases plasma taurine concentration in humans within taurine group, pre to post intervention.

    Human trialwithin taurine group, pre to post interventionplasma1.5 g16 wkfemalesn = 13

  2. Taurine increases plasma taurine concentration in patients with baseline plasma taurine below the normal limit.

    Human trialin patients with baseline plasma taurine below the normal limitoral solution, 1 g/50 mL1 g/50 mL three times a day4 weeksn = 5

  3. Taurine increases plasma taurine concentration in humans (acute oral dose of 1.66 g) (13-fold increase).

    Human trialacute oral dose of 1.66 g1.66 gone dayn = 7

  4. Taurine increases plasma taurine concentration in adults with short-bowel syndrome on long-term parenteral nutrition (63 (SE 8) v. 43 (SE 4) micromol/l, P=0.007).

    Human trialin adults with short-bowel syndrome on long-term parenteral nutritiontaurine-enriched parenteral nutrition6.0 (SE 0.6) mg/kg per d55 (SE 13) monthsn = 10

  5. Taurine increases plasma taurine concentration in humans (131.4±61.7 vs 38.9±6.7 micromol/l).

    Human trialplasma1.5 g8 weeksmalesn = 20

  6. Taurine increases plasma taurine concentration in humans (131 +/- 62 micromol/l after taurine vs 39 +/- 7 micromol/l after placebo).

    Human trial1.5 g daily8 weeksmalesn = 20

  7. Taurine increases plasma taurine concentration in diabetic patients (reached the mean values of healthy control subjects).

    Human trialin diabetic patients1.5 g/d90 dn = 39

  8. Taurine increases plasma taurine concentration in humans (intravenous taurine given to long-term parenteral nutrition patients) (normalized to normal values).

    Human trialintravenous taurine given to long-term parenteral nutrition patients10 mg/kg/day

  9. Taurine increases plasma taurine concentration in humans (decreased plasma concentrations).

    Reviewdecreased plasma concentrations

More on Plasma taurine concentration

Cellular senescence

downin mouse cells3downin cells2downin mice2downin human cells1

8 studies
  1. Taurine decreases cellular senescence in mouse cells (D-galactose-induced senescence in C2C12 myoblasts).

    CellsD-galactose-induced senescence in C2C12 myoblasts

    Taurine extended running time in aging-prone mice

    Amino acids
  2. Taurine decreases cellular senescence in cells (H2O2-induced senescence model).

    CellsH2O2-induced senescence modelnucleus pulposus progenitor cell

  3. Taurine decreases cellular senescence in mice.

    Animalslung

  4. Taurine decreases cellular senescence in human cells (si-Bmi-1 knockdown in human dermal fibroblasts).

    Cellssi-Bmi-1 knockdown in human dermal fibroblasts

  5. Taurine decreases cellular senescence in naturally aging and chemically induced senescent β-cells.

    Cellsin naturally aging and chemically induced senescent β-cellspancreatic β-cell

  6. Taurine decreases cellular senescence in vitro, mouse spleen cells (P<0.0001).

    Cellsin vitro, mouse spleen cellsspleen

  7. Taurine decreases cellular senescence in mice (CCl4-treated mice).

    AnimalsCCl4-treated miceliver

  8. Taurine decreases cellular senescence in cells.

    Cellsnucleus pulposus cells

More on Cellular senescence

Lifespan

upin mice3upin worms2downin flies1no changein flies1+1

7 studies
  1. Taurine improves lifespan in SICM mice.

    Animalsin SICM mice

  2. Taurine extends lifespan in silico (predicted by AgeXtend; excluded from training data).

    In silicopredicted by AgeXtend; excluded from training data

  3. Taurine extends lifespan in worms (reversal of taurine deficiency).

    Model organismsreversal of taurine deficiency

  4. Taurine extends lifespan in mice.

    Animals

  5. Taurine extends lifespan in mice (reversing age-associated taurine loss).

    Animalsreversing age-associated taurine loss

  6. Taurine extends lifespan in worms.

    Model organisms

  7. Taurine shortens lifespan in flies (Compared with the normal group).

    Model organismsCompared with the normal group1.6%

  8. Taurine showed no clear effect on lifespan in flies (lifetime feeding).

    Model organismslifetime feeding0.05 to 0.20 Mlifetime

Blood pressure

downin humans4downin reviews2no changein humans1

7 studies
  1. Taurine decreases blood pressure in prehypertensive individuals (clinic systolic BP reduction 7.2 mm Hg (taurine) vs 2.6 mm Hg (placebo)).

    Human trialin prehypertensive individuals1.6 g per day12 weeksn = 120

  2. Taurine decreases blood pressure in humans (acute administration).

    Human trialacute administration1000-2000 mgacuten = 102

  3. Taurine showed no clear effect on blood pressure in humans during 3-week diet period.

    Human trialduring 3-week diet periodpowder6 g/day3 weeksmales

  4. Taurine decreases blood pressure in hypertensive patients.

    Reviewin hypertensive patients

  5. Taurine decreases blood pressure.

    Review

  6. Taurine decreases blood pressure in humans (measured as 24-hour urinary taurine excretion).

    Reviewmeasured as 24-hour urinary taurine excretion

  7. Taurine decreases blood pressure.

    Review

More on Blood pressure

Mitochondrial function

upin reviews2downin cells1upin cells1no changein humans1+1

6 studies
  1. Taurine was not clearly linked with mitochondrial function in humans (circulating taurine in physically inactive and active men).

    Humanscirculating taurine in physically inactive and active menmalesn = 137

  2. Taurine improves mitochondrial function (preclinical studies).

    Reviewpreclinical studies

  3. Taurine protects against mitochondrial function in cells (H2O2-induced senescence model).

    CellsH2O2-induced senescence modelnucleus pulposus progenitor cell

  4. Taurine improves mitochondrial function in postovulatory aged oocytes.

    Cellsin postovulatory aged oocytes

  5. Taurine improves mitochondrial function in pig cells (postovulatory aging (POA) oocytes).

    Cellspostovulatory aging (POA) oocytesoocyte

  6. Taurine improves mitochondrial function in MELAS model cells.

    Reviewin MELAS model cells

Mortality

downin mice3no changein humans2no changein mice1RR 0.7

6 studies
  1. Taurine showed no clear effect on mortality in humans (pooled from two randomized trials) (RR 0.70, 95% CI 0.28 to 1.80).

    Human trialpooled from two randomized trialstaurine-enhanced enteral nutritionn = 176

  2. Taurine showed no clear effect on mortality in humans.

    Human trialup to six days after surgeryn = 236

  3. Taurine decreases mortality in mice (sepsis and inflammasome-mediated inflammation).

    Animalssepsis and inflammasome-mediated inflammation

    Raising taurine improves health during aging in mice

    Cell
  4. Taurine protects against mortality in mice.

    Animalsserum1 year

  5. Taurine showed no clear effect on mortality in mice (given alone, without the other agent).

    Animalsgiven alone, without the other agent

  6. Taurine decreases mortality in mice.

    AnimalsEhrlich ascites carcinoma-bearing mice receiving ifosfamide, compared with ifosfamide alone1% in drinking water

Blood lactate

upin humans2downin humans2no changein humans2

6 studies
  1. Taurine increases blood lactate in humans during exhaustive exercise under hot and humid conditions (T group peak values higher than P group (P = 0.04)).

    Human trialduring exhaustive exercise under hot and humid conditionsn = 12

  2. Taurine decreases blood lactate in humans (d = 0.8 versus CAF; d = 0.7 versus TAU + CAF).

    Human trialafter the exhaustion test, versus caffeine alone (also lower than taurine plus caffeine, d = 0.7)

  3. Taurine showed no clear effect on blood lactate in humans (compared with placebo, 1 h before Wingate test).

    Human trialcompared with placebo, 1 h before Wingate test4 g and 6 gfemales

  4. Taurine decreases blood lactate in humans (measured after exercise in the heat (35°C, 40% RH)) (−16.5% (5.75 mmol L−1 vs. 6.85 mmol L−1)).

    Human trialmeasured after exercise in the heat (35°C, 40% RH)50 mg kg−1malesn = 11

  5. Taurine increases blood lactate in humans after the ramp test, versus placebo (d = 4.7).

    Human trialafter the ramp test, versus placebo50 mg/kg body massfemalesn = 9

  6. Taurine showed no clear effect on blood lactate in humans (measured before and after the time trial, with pH and HCO3− showing the same pattern) (no condition main effect (p > 0.05)).

    Human trialmeasured before and after the time trial, with pH and HCO3− showing the same patternblood1000 mgmalesn = 11

More on Blood lactate

Malondialdehyde

downin humans2downin O. cuniculus2downin rats2

6 studies
  1. Taurine decreases malondialdehyde in humans (SMD = -1.17 μmol/l; 95% CI: -2.08, -0.26).

    Human trial

  2. Taurine decreases malondialdehyde in humans during maintenance chemotherapy for acute lymphoblastic leukemia.

    Human trialduring maintenance chemotherapy for acute lymphoblastic leukemia

  3. Taurine decreases malondialdehyde in BSO-induced glutathione depletion.

    Animalsin BSO-induced glutathione depletionlens

  4. Taurine decreases malondialdehyde in dichlorvos-exposed rats.

    Animalsin dichlorvos-exposed rats50 mg/kg4 weeksn = 10

  5. Taurine decreases malondialdehyde in rats (ovariectomized rats fed cholesterol).

    Animalsovariectomized rats fed cholesterolliver20 g/kg dietfemales

  6. Taurine decreases malondialdehyde in O. cuniculus across all lenses in glucose and galactose media (r = -0.53).

    Animalsacross all lenses in glucose and galactose medialens72 h

More on Malondialdehyde

Systolic blood pressure

downin humans5

5 studies
  1. Taurine decreases systolic blood pressure in humans (Hedges' g = -0.70; mean ~3 mmHg (range 0-15 mmHg)).

    Human trial1 to 6 g/day1 day to 12 weeksn = 103

  2. Taurine decreases systolic blood pressure in human intervention trials (7 mmHg reduction).

    Reviewin human intervention trials

  3. Taurine decreases systolic blood pressure in humans (WMD -3.999 mm Hg (95% CI -7.293 to -0.706)).

    Reviewn = 808

  4. Taurine decreases systolic blood pressure in humans (compared with control groups in meta-analysis of RCTs) (WMD -3.999 mmHg, 95% CI -7.293 to -0.706).

    Reviewcompared with control groups in meta-analysis of RCTsn = 1,024

  5. Taurine decreases systolic blood pressure in patients with liver dysregulation (WMD -4.67 mm Hg; 95%CI -9.10 to -0.25).

    Reviewin patients with liver dysregulation

More on Systolic blood pressure

Superoxide dismutase

upin rats3upin humans2

5 studies
  1. Taurine increases superoxide dismutase in humans (compared with placebo).

    Human trialcompared with placeboplasma1.5 g16 wkfemalesn = 24

  2. Taurine increases superoxide dismutase in human intervention trials.

    Reviewin human intervention trials1.5–6.0 g/day8–16 weeks

  3. Taurine increases superoxide dismutase in dichlorvos-exposed rats (P = 0.0273).

    Animalsin dichlorvos-exposed rats50 mg/kg4 weeksn = 10

  4. Taurine increases superoxide dismutase in rats (ovariectomized rats fed cholesterol).

    Animalsovariectomized rats fed cholesterolliver20 g/kg dietfemales

  5. Taurine increases superoxide dismutase in rats.

    Animalstestismales

More on Superoxide dismutase

C-reactive protein

downin humans3no changein humans2

5 studies
  1. Taurine showed no clear effect on C-reactive protein in humans (pooled from two randomized trials) (MD -0.41, 95% CI -1.35 to 0.54).

    Human trialpooled from two randomized trialstaurine-enhanced enteral nutritionn = 60

  2. Taurine decreases C-reactive protein in humans (SMD = -1.95 mg/l; 95% CI: -3.20, -0.71).

    Human trial

  3. Taurine decreases C-reactive protein in humans (combined with weight-loss diet, compared with weight-loss diet alone) (p = 0.03 vs control group).

    Human trialcombined with weight-loss diet, compared with weight-loss diet alonecapsule3 g/day8 weeksfemales

  4. Taurine decreases C-reactive protein in humans (before and after incremental exercise in heart failure patients).

    Human trialbefore and after incremental exercise in heart failure patients500 mg three times a day2 weeks

  5. Taurine showed no clear effect on C-reactive protein in humans (compared with control group; TNF-α also not significantly changed).

    Human trialcompared with control group; TNF-α also not significantly changed50 mg/kg per day10 daysn = 30

More on C-reactive protein

Cognitive function

no changein humans2upin reviews2

4 studies
  1. Taurine showed no clear effect on cognitive function in humans (adjunctive to low-dose antipsychotic medication) (95% CI -1.7 to 1.0; P = .582).

    Human trialadjunctive to low-dose antipsychotic medication4 g once daily12 weeksn = 86

  2. Taurine improves cognitive function in Alzheimer's disease models.

    Reviewin Alzheimer's disease models

  3. Taurine showed no clear effect on cognitive function in humans (alone or in combination with exercise training).

    Reviewalone or in combination with exercise training

  4. Taurine improves cognitive function (cognitive impairment of physiological, pathological and toxicological origin).

    Reviewcognitive impairment of physiological, pathological and toxicological origin

All 539

What is taurine linked with?

39

Studies link taurine with 39 measures, among them cell volume regulation, apoptosis and colorectal cancer.

cell volume regulation

mixedin reviews2upin reviews1no changein reviews1

4 studies
  1. Taurine is associated with cell volume regulation.

    Reviewbrain

  2. Taurine is associated with cell volume regulation (together with other small-molecular compounds).

    Reviewtogether with other small-molecular compoundsbrain

  3. Taurine is associated with cell volume regulation.

    Reviewcentral nervous system

  4. Taurine is associated with cell volume regulation.

    Review

Apoptosis

mixedin reviews3mixedin cells1

4 studies
  1. Taurine is associated with apoptosis in cells.

    Cellshigh levels

  2. Taurine is associated with apoptosis (shift in taurine transporter expression or cellular taurine content).

    Reviewshift in taurine transporter expression or cellular taurine content

  3. Taurine is associated with apoptosis.

    Reviewkidney

  4. Taurine is associated with apoptosis.

    Review

More on Apoptosis

Colorectal cancer

upin humans2

2 studies
  1. Taurine is linked with a higher risk of colorectal cancer in humans.

    Humansn = 1,714

  2. Taurine raises the risk of colorectal cancer in humans (high-dose supplementation acting via taurine-conjugated bile acid pathways).

    Reviewhigh-dose supplementation acting via taurine-conjugated bile acid pathwayssupplementalhigh-dose

More on Colorectal cancer

MMSE score

upin humans1

1 study
  1. Taurine is associated with MMSE score in humans (Alzheimer's disease clinical spectrum and healthy controls) (r = 0.45, BH-FDR Q = 0.0005).

    HumansAlzheimer's disease clinical spectrum and healthy controlsstool

Intervertebral disc degeneration

downin humans1

1 study
  1. Taurine is linked with a lower risk of intervertebral disc degeneration in humans (Mendelian randomization analysis of higher taurine levels).

    HumansMendelian randomization analysis of higher taurine levels

More on Intervertebral disc degeneration

Gut microbiota

upin O. aries1

1 study
  1. Taurine is associated with gut microbiota in O. aries.

    Animalsgut

Mortality

downin humans1

1 study
  1. Taurine lowers the risk of mortality in humans (versus placebo, in liver transplant recipients) (p < 0.05).

    Human trialversus placebo, in liver transplant recipients2 g/day30 daysn = 169

N-acetylaspartate and glutamate concentrations

mixedin mice1

1 study
  1. Taurine is associated with N-acetylaspartate and glutamate concentrations in mice (5xFAD mice, compared with wild-type metabolite levels).

    Animals5xFAD mice, compared with wild-type metabolite levels

More on N-acetylaspartate and glutamate concentrations

Cardiometabolic outcomes

mixedin reviews1

1 study
  1. Taurine is associated with cardiometabolic outcomes.

    Review

Immune and inflammation outcomes

upin reviews1

1 study
  1. Taurine is associated with immune and inflammation outcomes.

    Review

Change in HOMA-IR

mixedin humans1

1 study
  1. Taurine is associated with change in HOMA-IR in humans (interaction with diabetes genetic risk score during 2-year weight-loss diet) (P-interaction = .002).

    Human trialinteraction with diabetes genetic risk score during 2-year weight-loss diet2 yearsn = 711

More on Change in HOMA-IR

Tear protein subset

mixedin humans1

1 study
  1. Taurine is associated with tear protein subset in humans (linear response across six time points) (R2 ≥0.5).

    Human triallinear response across six time pointseye dropstears0.05%5 weeksn = 4

More on Tear protein subset

Muscle amino acid response to exercise

mixedin humans1

1 study
  1. Taurine is associated with muscle amino acid response to exercise in humans after 7 days of supplementation, following exercise.

    Human trialafter 7 days of supplementation, following exerciseskeletal muscle5 g/day7 daysmalesn = 8

More on Muscle amino acid response to exercise

All 39

What acts on taurine?

1

Studies name hypotaurine as acting on taurine.

Hypotaurine

upin silico1

1 study
  1. Hypotaurine increases taurine in silico (calculated rate of hypotaurine oxidation by superoxide).

    In silicocalculated rate of hypotaurine oxidation by superoxide

More on Hypotaurine

Has taurine been tested in people?

3 of 21 about aging

Yes: 144 trials and 35 observational studies in people have been published, and 21 trials are registered.

Every condition in trials

All 18

Who is developing taurine?

1 company: Société des Produits Nestlé (SPN).

Companies
  • Société des Produits Nestlé (SPN)

Trial sponsors

Funding

9 grants since 2020

National Institute on Aging$3.7MGouvernement du Canada | Canadian Institutes of Health ResearchCA$4.6MNational Cancer Institute$536K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Taurine extends worm lifespan across independent labs and improves healthspan in mice and monkeys, but fly studies report unchanged or shorter lifespan. Human trials report no clear effect on physical function in males or mortality after surgery; two registered trials concern aging, while six trials overall ended over a year ago without posted results. Some papers have company-affiliated authors or declared company ties.

  2. Summary rewritten as its findings changed.

    As it read before

    Independent labs report that taurine extends worm lifespan; a monkey study reports improved healthspan, while a fly study finds no lifespan effect. Human trials report both reduced and unchanged IL-6. Assessed registrations include no aging-focused trials; seven ended over a year ago without posted results or citing papers, and papers disclose Taisho Pharmaceutical affiliations and ties.

  3. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 20Feb 2026: 27Mar 2026: 17Apr 2026: 4May 2026: 5Jun 2026: 7Jul 2026: 8Aug 2026: 4Sep 2026: 5Oct 2026: 9Nov 2026: 6117 papers in 12 months
Cell

Raising taurine improves health during aging in mice

Experiments in aged mice found better health span and fewer deaths from sepsis and inflammation after researchers raised taurine levels.Experiments in aged mice found better health span and fewer deaths from sepsis and inflammation after researchers raised taurine levels.

Mouse studyTaurine
Journal of Agricultural and Food Chemistry

Food contaminant restricts fetal growth in mice

Mouse experiments linked restricted fetal growth to senescence, a state in which cells stop dividing, in the placenta’s blood vessels.Mouse experiments linked restricted fetal growth to senescence, a state in which cells stop dividing, in the placenta’s blood vessels.

Mouse studyMechanisms

See all 559 papers on taurine